Latest Health News
JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) -- These statements have not…
Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026
SHERMAN OAKS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Dr. Austin Harris,…
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
June 19, 2026 16:02 ET | Source: Eupraxia Pharmaceuticals Inc. VANCOUVER, British…
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
AURORA, CO, June 19, 2026 (GLOBE NEWSWIRE) -- These statements have not…
Invitation to attend the extraordinary shareholders meeting of the Company to be held on July 9, 2026
REGULATED INFORMATIONJune 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA(Euronext Brussels/Nasdaq:…
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 19, 2026 16:05 ET | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., June…
Glass House Brands Announces Voting Results Following Annual Meeting
June 19, 2026 07:30 ET | Source: Glass House Brands Inc. LONG…
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
~ AMT-260 was generally well-tolerated with no serious adverse events observed to…
Press Release: Sanofis Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma…
